Glenview Capital Management

Glenview Capital Management
Name	Glenview Capital Management
Type	Private
Industry	Hedge fund
Founded	2000
Founder	Henry R. Kaufman? (see body)
Headquarters	New York City
Products	Investment funds, private equity, activist campaigns

Glenview Capital Management is a private investment firm founded in 2000 and based in New York City that has been active in healthcare, insurance, and consumer-facing industries. The firm has pursued concentrated long/short equity strategies, engaged in corporate activism, and operated multiple pooled investment vehicles and separately managed accounts. Glenview has been prominent in transactions involving public companies, private placements, and structured financings, engaging with institutional investors, sovereign wealth funds, and retirement plans.

History

Glenview was founded at the turn of the 21st century and expanded through the 2000s and 2010s via fund launches and marquee corporate stakes. Early years involved activist positions and event-driven investments tied to industry consolidation in healthcare names and negotiations with boards of directors at public corporations such as hospital systems and pharmaceutical firms. The firm navigated the 2008–2009 financial crisis alongside peers including Elliott Management, Pershing Square Capital Management, and Greenlight Capital, adapting its risk controls and portfolio construction after periods of market stress. In the 2010s, Glenview deployed capital into insurance conglomerates, medical device manufacturers, and specialty pharmaceutical companies while interacting with counterparties like investment banks and private equity sponsors. The firm’s timeline includes launching dedicated flagship funds, establishing separately managed accounts for family offices, and participating in secondary market transactions with asset managers such as BlackRock, Vanguard Group, and State Street. Corporate governance engagements brought Glenview into proxy contests, boardroom negotiations, and merger discussions involving public companies listed on exchanges such as the New York Stock Exchange and NASDAQ.

Investment Strategy and Funds

Glenview’s investment approach combines concentrated equity positions, fundamental research, and active engagement with management teams and boards. The strategy often targets sectors with regulatory complexity and consolidation potential—notably healthcare providers, health insurance carriers, and medical technology firms—where operational improvements or strategic transactions can unlock value. Glenview has offered hedge funds, long-only vehicles, and co-investment opportunities to investors including pension funds and endowments. Fund structures have included both onshore managed accounts and offshore feeder funds to accommodate investors from jurisdictions such as United Kingdom, Cayman Islands, and Luxembourg. Risk management practices incorporate liquidity analysis, position concentration limits, and derivative overlays with counterparties like Goldman Sachs, Morgan Stanley, and J.P. Morgan Chase. The firm’s capital-raising cycles intersected with capital markets activities including secondary offerings, private placements, and negotiated buyouts alongside firms like KKR, The Carlyle Group, and Apollo Global Management.

Notable Investments and Exits

Glenview has taken large positions in publicly traded healthcare and insurance companies and executed exits via strategic sales, mergers, or public-to-private transactions. Its campaigns have intersected with transactions involving companies tied to hospital chains, pharmacy benefit managers, and managed care organizations, sometimes resulting in board changes or asset divestitures. Exits were achieved through negotiated sales, block trades with broker-dealers, and participation in take-private transactions executed by private equity firms or corporate buyers. The firm has been linked in market commentary to stakes in household names and industry leaders whose outcomes affected shareholder constituencies including institutional investors and retail holders. In several instances, Glenview’s disposition of positions coincided with sector M&A waves, regulatory decisions by agencies like the Centers for Medicare & Medicaid Services, and pricing shifts on exchanges such as the NYSE American.

Leadership and Organization

Glenview’s leadership has included senior portfolio managers, research analysts, and operations professionals with prior experience at prominent investment firms, academic institutions, and regulatory bodies. The firm’s organizational structure supports concentrated research teams focused on healthcare sub-sectors, compliance units aligned with rules from regulators such as the Securities and Exchange Commission, and trading desks that liaise with prime brokers including Citigroup and Deutsche Bank. Senior personnel have participated in industry conferences hosted by organizations like AQR Capital Management-adjacent forums, National Association of Insurance Commissioners meetings, and investor summits where asset managers and corporate executives convene. Governance at the firm includes risk committees, compliance officers, and investor relations staff interfacing with limited partners such as university endowments and sovereign wealth funds.

Performance and Assets Under Management

Glenview’s assets under management (AUM) have fluctuated with market conditions, fund inflows and redemptions, and realized gains from exits. Performance track records have reflected returns driven by concentrated bets in healthcare and financial services, with periods of outperformance relative to hedge fund indices and intervals of drawdown concurrent with sector volatility. The firm reported AUM that placed it among mid-sized hedge funds, engaging with allocators from pension funds, insurance companies, and family offices. Returns have been benchmarked informally against indices like the S&P 500, MSCI World, and healthcare sector indices maintained by data providers such as Bloomberg and S&P Global.

Regulatory and Legal Issues

As an active investor in regulated sectors, Glenview has been subject to regulatory oversight, disclosure requirements under Securities Exchange Act of 1934 provisions, and reporting obligations administered by the Securities and Exchange Commission. The firm’s activist engagements and large equity stakes have at times prompted public filings, proxy disclosures, and communications with corporate registrars and transfer agents. Legal matters involving hedge funds commonly entail litigation over fiduciary duties, arbitration with service providers, or inquiries related to trading practices; Glenview’s operational history includes routine regulatory interactions and compliance responses typical for investment managers operating across multiple jurisdictions. The firm has also navigated regulatory developments affecting healthcare reimbursement and insurance regulation, which influenced investment theses and portfolio positioning.

Category:Hedge funds Category:Investment management firms